The natural history of a T1 bladder cancer: Life-long tumour diathesis

BJU International

Volumn 84, Issue 9, 1999, Pages 1102-1103

  Herr, H W ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; CISPLATIN; IFOSFAMIDE; PACLITAXEL;

ADULT; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FOLLOW UP; HUMAN; INTRAVENOUS PYELOGRAPHY; MALE; NEPHROURETERECTOMY; PRIORITY JOURNAL; TRANSURETHRAL RESECTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA IN SITU; CISPLATIN; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE SUSCEPTIBILITY; DOXORUBICIN; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0032740609     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00370.x     Document Type: Article

References (6)

1. 1 Herr HW. Transurethral resection alone in selected patients with Tl tumor. Sem Urol Oncol 1997; 15: 142-7
2. 2 Herr HW. Tumour progression and survival in patients with Tl G3 bladder tumours: 15-year outcome. Br J Urol 1997; 80: 62-5
3. 3 Herr HW, Hilton S. Routine CT scan in cystectomy patients. Does it change management? Urology 1996; 47: 324-5
4. 4 Donat SM, Herr HW, Bajorin DF et al. MVAC chemotherapy and cystectomy for unresectable bladder cancer. J Urol 1996; 156: 368-71
5. 5 Bajorin DF, McCaffrey JA, Hilton S et al. Treatment of patients with transitional cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: A phase II trial. J Clin Oncol 1998; 16: 2722-7
6. 6 Herr HW. Extravesical tumor relapse in patients with superficial bladder tumors. J Clin Oncol 1998; 16: 1099-1102